Referências
Principais artigos
Krowchuk DP, Frieden IJ, Mancini AJ, et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019 Jan;143(1): e20183475.Texto completo Resumo
Darrow DH, Greene AK, Mancini AJ, et al. Diagnosis and management of infantile hemangioma. Pediatrics. 2015 Oct;136(4):e1060-104.Texto completo Resumo
Artigos de referência
1. Krowchuk DP, Frieden IJ, Mancini AJ, et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019 Jan;143(1): e20183475.Texto completo Resumo
2. Garzon MC. Infantile hemangioma. In: Callen JP, Horn TD, Mancini AJ, et al, eds. Dermatology. Vol. 2. 2nd ed. St. Louis, MO: Elsevier; 2008:1565-80.
3. Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008 Aug;122(2):360-7. Resumo
4. Requena L, Sangueza OP. Cutaneous vascular proliferations. Part II. Hyperplasias and benign neoplasms. J Am Acad Dermatol. 1997 Dec;37(6):887-919. Resumo
5. Wananukul S. Clinical manifestation and management of hemangiomas of infancy. J Med Assoc Thai. 2002 Jun;85(suppl 1):S280-5. Resumo
6. Haggstrom AN, Lammer EJ, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics. 2006 Mar;117(3):698-703. Resumo
7. Chiller KG, Passaro D, Friedan IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity and sex. Arch Dermatol. 2002 Dec;138(12):1567-76.Texto completo Resumo
8. Metry D, Heyer G, Hess C, et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics. 2009 Nov;124(5):1447-56. Resumo
9. Goldberg NS, Hebert AA, Esterly NB. Sacral hemangioma and multiple congenital abnormalities. Arch Dermatol. 1986 Jun;122(6):684-7. Resumo
10. Grevelink SV, Mulliken JB. Vascular anomalies and tumors of skin and subcutaneous tissues. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's dermatology in general medicine. Vol. 1. 6th ed. New York, NY: McGraw-Hill; 2003:1002-26.
11. Glick ZR, Frieden IJ, Garzon MC, et al. Diffuse neonatal hemangiomatosis: an evidence-based review of case reports in the literature. J Am Acad Dermatol. 2012 Nov;67(5):898-903. Resumo
12. Horii KA, Drolet BA, Frieden IJ, et al. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol. 2011 May-Jun;28(3):245-53. Resumo
13. Paller A, Mancini A. Hurwitz clinical pediatric dermatology. 4th ed. Philadelphia, PA: Saunders; 2011:268-302.
14. Darrow DH, Greene AK, Mancini AJ, et al. Diagnosis and management of infantile hemangioma. Pediatrics. 2015 Oct;136(4):e1060-104.Texto completo Resumo
15. Kilcline C, Friedan IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol. 2008 Mar-Apr;25(2):168-73. Resumo
16. Bruckner AL, Friedan IJ. Hemangiomas of infancy. J Am Acad Dermatol. 2003 Apr;48(4):477-93. Resumo
17. Drolet BA, Swanson EA, Frieden IJ, et al. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr. 2008 Nov;153(5):712-5. Resumo
18. Smith CJF, Friedlander SF, Guma M, et al. Infantile hemangiomas: an updated review on risk factors, pathogenesis, and treatment. Birth Defects Res. 2017 Jul 3;109(11):809-15.Texto completo Resumo
19. Hemangioma Investigator Group, Haggstrom AN, Drolet, BA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007 Mar;150(3):291-4. Resumo
20. Barnes CM, Christison-Lagay EA, Folkman J. The placenta theory and the origin of infantile hemangioma. Lymphat Res Biol. 2007;5(4):245-55. Resumo
21. Pittman KM, Losken HW, Kleinman ME, et al. No evidence for maternal-fetal microchimerism in infantile hemangioma: a molecular genetic investigation. J Invest Dermatol. 2006 Nov;126(11):2533-8.Texto completo Resumo
22. Regnier S, Dupin N, Le Danff C, et al. Endothelial cells in infantile haemangiomas originate from the child and not from the mother (a fluorescence in situ hybridization-based study). Br J Dermatol. 2007 Jul;157(1):158-60. Resumo
23. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006 Sep;118(3):882-7. Resumo
24. American College of Radiology. ACR appropriateness criteria: soft tissue vascular anomalies: vascular malformations and infantile vascular tumors (non-CNS)-child. 2023 [internet publication].Texto completo
25. Paltiel HJ, Burrows PE, Kozakewich HP, et al. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology. 2000 Mar;214(3):747-54. Resumo
26. Kern S, Niemeyer C, Darge K, et al. Differentiation of vascular birthmarks by MR imaging. An investigation of hemangiomas, venous and lymphatic malformations. Acta Radiol. 2000 Sep;41(5):453-7. Resumo
27. Kitami M. Diffusion-weighted imaging as a routine MRI protocol for the evaluation of 'infantile hemangioma'. Clin Imaging. 2017 Nov - Dec;46:121. Resumo
28. Weedon D. Vascular tumors. In: Houston MJ, ed. Skin pathology. 2nd ed. New York, NY: Churchill Livingston; 2002:1001-43.
29. North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangioma. Hum Pathol. 2000 Jan;31(1):11-22. Resumo
30. Bree AF, Siegfried E, Sotelo-Avila C, et al. Infantile hemangioma: speculation on placental trophoblastic origin. Arch Dermatol. 2001 May;137(5):573-7.Texto completo Resumo
31. North PE, Waner M, James CA, et al. Congenital nonprogressive hemangioma: a distinct clinicopathological entity unlike infantile hemangioma. Arch Dermatol. 2001 Dec;137(12):1607-20.Texto completo Resumo
32. Metry DW, Dowd CF, Barkovich AJ, et al. The many faces of PHACE syndrome. J Pediatr. 2001 Jul;139(1):117-23. [Erratum in: J Pediatr 2001 Sep;139(3):470.] Resumo
33. Legiehn GM, Heran MK. Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin North Am. 2008 May;46(3):545-97. Resumo
34. Enjolras O. Vascular malformations. In: Callen JP, Horn TD, Mancini AJ, et al, eds. Dermatology. Vol. 2. 2nd ed. St. Louis, MO: Elsevier; 2008:1581-95.
35. Pandey A, Gangopadhyay AN, Sharma SP, et al. Conservative management of ulcerated haemangioma - twenty years experience. Int Wound J. 2009 Feb;6(1):59-62. Resumo
36. Berenguer B, Mulliken JB, Enjolras O, et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol. 2003 Nov-Dec;6(6):495-510. Resumo
37. Requena C, Miranda L, Canete A, et al. Congenital fibrosarcoma simulating congenital hemangioma. Pediatr Dermatol. 2008 Jan-Feb;25(1):141-4. Resumo
38. Yan AC, Chamlin SL, Liang MG, et al. Congenital infantile fibrosarcoma: a masquerader of ulcerated hemangioma. Pediatr Dermatol. 2006 Jul-Aug;23(4):330-4. Resumo
39. North PE, Kincannon J. Vascular neoplasms and neoplastic-like proliferations. In: Callen JP, Horn TD, Mancini AJ, et al, eds. Dermatology. Vol. 2. 2nd ed. St. Louis, MO: Elsevier; 2008:1771-94.
40. Zwicker K, Powell J, Cummings C. Vascular anomalies in childhood: When to treat and when to refer. Paediatr Child Health. 2022 Sep;27(5):310-4. Resumo
41. Izadpanah A, Izadpanah A, Kanevsky J, et al. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg. 2013 Mar;131(3):601-13. Resumo
42. Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013 Jan;131(1):128-40. Resumo
43. Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015 Feb 19;372(8):735-46.Texto completo Resumo
44. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008 Jun 12;358(24):2649-51. Resumo
45. Zaher H, Rasheed H, Hegazy RA, et al. Oral propranolol: an effective, safe treatment for infantile hemangiomas. Eur J Dermatol. 2011 Jul-Aug;21(4):558-63. Resumo
46. Fuchsmann C, Quintal MC, Giguere C, et al. Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg. 2011 May;137(5):471-8. Resumo
47. Missoi TG, Lueder GT, Gilbertson K, et al. Oral propranolol for treatment of periocular infantile hemangiomas. Arch Ophthalmol. 2011 Jul;129(7):899-903. Resumo
48. Peridis S, Pilgrim G, Athanasopoulos I, et al. A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol. 2011 Apr;75(4):455-60. Resumo
49. Hong E, Fischer G. Propranolol for recalcitrant ulcerated hemangioma of infancy. Pediatr Dermatol. Pediatr Dermatol. 2012 Jan-Feb;29(1):64-7. Resumo
50. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr. 2010 Aug;157(2):340-2. Resumo
51. Marqueling AL, Oza V, Frieden IJ, et al. Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013 Mar-Apr;30(2):182-91. Resumo
52. de Graaf M, Breur JM, Raphael MF, et al. Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants. J Am Acad Dermatol. 2011 Aug;65(2):320-7. Resumo
53. Holland KE, Frieden IJ, Frommelt PC, et al. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol. 2010 Jul;146(7):775-8.Texto completo Resumo
54. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009 Sep-Oct;26(5):610-4.Texto completo Resumo
55. Ni N, Langer P, Wagner R, et al. Topical timolol for periocular hemangioma: report of further study. Arch Ophthalmol. 2011 Mar;129(3):377-9. Resumo
56. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol. 2010 May;146(5):564-5.Texto completo Resumo
57. National Institute for Health and Care Excellence. Infantile haemangioma: topical timolol. Aug 2015 [internet publication].Texto completo
58. Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics. 2007 Jun;119(6):e1239-47. Resumo
59. Rossler J, Wehl G, Niemeyer CM. Evaluating systemic prednisone therapy for proliferating haemangioma in infancy. Eur J Pediatr. 2008 Jul;167(7):813-5. Resumo
60. Bennett ML, Fleischer AB Jr., Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol. 2001 Sep;137(9):1208-13. Resumo
61. George ME, Sharma V, Jacobson J, et al. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol. 2004 Aug;140(8):963-9.Texto completo Resumo
62. Lomenick JP, Reifschneider KL, Lucky AW, et al. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol. 2009 Mar;145(3):262-6. Resumo
63. Chantharatanapiboon W. Intralesional corticosteroid therapy in hemangiomas: clinical outcome in 160 cases. J Med Assoc Thai. 2008 Oct;91(suppl 3):S90-6. Resumo
64. Chen MT, Yeong EK, Horng SY. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. J Pediatr Surg. 2000 Mar;35(3):420-3. Resumo
65. Buckmiller LM, Francis CL, Glade RS. Intralesional steroid injection for proliferative parotid hemangiomas. Int J Pediatr Otorhinolaryngol. 2008 Jan;72(1):81-7. Resumo
66. Jalil S, Akhtar J, Ahmed S. Corticosteroids therapy in the management of infantile cutaneous hemangioma. J Coll Physicians Surg Pak. 2006 Oct;16(10):662-5. Resumo
67. Sinno H, Thibaudeau S, Coughlin R, et al. Management of infantile parotid gland hemangiomas: a 40-year experience. Plast Reconstr Surg. 2010 Jan;125(1):265-73. Resumo
68. Batta K, Goodyear HM, Moss C, et al. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet. 2002 Aug 17;360(9332):521-7. Resumo
69. Stier MF, Click SA, Hirsch RJ. Laser treatment of pediatric vascular lesions: port-wine stains and hemangiomas. J Am Acad Dermatol. 2008 Feb;58(2):261-85. Resumo
70. Smit JM, Bauland CG, Wijnberg DS, et al. Pulsed dye laser treatment, a review of indications and outcome based on published trials. Br J Plast Surg. 2005 Oct;58(7):981-7. Resumo
71. Brightman LA, Brauer JA, Terushkin V, et al. Ablative fractional resurfacing for involuted hemangioma residuum. Arch Dermatol. 2012 Nov;148(11):1294-8.Texto completo Resumo
72. Brandling-Bennett HA, Metry DW, Baselga E, et al. Infantile hemangiomas with unusually prolonged growth phase: a case series. Arch Dermatol. 2008 Dec;144(12):1632-7. Resumo
73. Li G, Xu D, Hu Z, et al. Embolic retinal and choroidal vascular occlusion after peribulbar triamcinolone injection: a case report. Medicine (Baltimore). 2018 Apr;97(17):e0467.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal